Inari Medical, Inc. Research and Development Expense
Inari Medical, Inc. reported Research and Development Expense of $29.43 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-10-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-10-28
- Inari Medical, Inc. research and development expense for the quarter ending 2024-09-30 was $29.43M, a 36.94% increase year-over-year.
- Inari Medical, Inc. research and development expense for the quarter ending 2024-06-30 was $24.91M, a 18.12% increase year-over-year.
- Inari Medical, Inc. research and development expense for the quarter ending 2024-03-31 was $26.88M, a 21.83% increase year-over-year.
- Inari Medical, Inc. research and development expense for the quarter ending 2023-12-31 was $22.89M, a 12.15% increase year-over-year.
- Inari Medical, Inc. research and development expense for fiscal 2023 was $87.53M, a 17.94% increase from fiscal 2022.
- Inari Medical, Inc. research and development expense for fiscal 2022 was $74.22M, a 45.48% increase from fiscal 2021.
- Inari Medical, Inc. research and development expense for fiscal 2021 was $51.02M, a 177.29% increase from fiscal 2020.
- Inari Medical, Inc. research and development expense for fiscal 2020 was $18.40M, a 154.83% increase from fiscal 2019.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2024-09-30 | $29.43M 10-Q · filed 2024-10-28 | $54.34M derived: sum of 2 quarters · filed 2024-10-28 | $81.22M 10-Q · filed 2024-10-28 | $104.11M derived: sum of 4 quarters · filed 2024-10-28 |
| 2024-06-30 | $24.91M 10-Q · filed 2024-07-30 | $51.78M 10-Q · filed 2024-07-30 | $74.68M derived: sum of 3 quarters · filed 2024-07-30 | $96.17M derived: sum of 4 quarters · filed 2024-10-28 |
| 2024-03-31 | $26.88M 10-Q · filed 2024-04-30 | $49.77M derived: sum of 2 quarters · filed 2024-04-30 | $71.26M derived: sum of 3 quarters · filed 2024-10-28 | $92.35M derived: sum of 4 quarters · filed 2024-10-28 |
| 2023-12-31 | $22.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $44.38M derived: sum of 2 quarters · filed 2024-10-28 | $65.47M derived: sum of 3 quarters · filed 2024-10-28 | $87.53M 10-K · filed 2024-02-29 |
| 2023-09-30 | $21.49M 10-Q · filed 2024-10-28 | $42.58M derived: sum of 2 quarters · filed 2024-10-28 | $64.64M 10-Q · filed 2024-10-28 | $85.05M derived: sum of 4 quarters · filed 2024-10-28 |
| 2023-06-30 | $21.09M 10-Q · filed 2024-07-30 | $43.15M 10-Q · filed 2024-07-30 | $63.56M derived: sum of 3 quarters · filed 2024-07-30 | $82.67M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $22.06M 10-Q · filed 2024-04-30 | $42.48M derived: sum of 2 quarters · filed 2024-04-30 | $61.58M derived: sum of 3 quarters · filed 2024-04-30 | $80.15M derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | $20.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $39.52M derived: sum of 2 quarters · filed 2024-02-29 | $58.09M derived: sum of 3 quarters · filed 2024-02-29 | $74.22M 10-K · filed 2024-02-29 |
| 2022-09-30 | $19.11M 10-Q · filed 2023-11-01 | $37.67M derived: sum of 2 quarters · filed 2023-11-01 | $53.81M 10-Q · filed 2023-11-01 | $72.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $18.57M 10-Q · filed 2023-08-02 | $34.70M 10-Q · filed 2023-08-02 | $53.43M derived: sum of 3 quarters · filed 2024-02-29 | $65.93M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $16.14M 10-Q · filed 2023-05-03 | $34.86M derived: sum of 2 quarters · filed 2024-02-29 | $47.36M derived: sum of 3 quarters · filed 2024-02-29 | $58.99M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $18.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $31.23M derived: sum of 2 quarters · filed 2024-02-29 | $42.85M derived: sum of 3 quarters · filed 2024-02-29 | $51.02M 10-K · filed 2024-02-29 |
| 2021-09-30 | $12.50M 10-Q · filed 2022-11-02 | $24.13M derived: sum of 2 quarters · filed 2022-11-02 | $32.29M 10-Q · filed 2022-11-02 | $38.83M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $11.63M 10-Q · filed 2022-08-03 | $19.79M 10-Q · filed 2022-08-03 | $26.33M derived: sum of 3 quarters · filed 2023-02-27 | $31.55M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $8.16M 10-Q · filed 2022-05-04 | $14.70M derived: sum of 2 quarters · filed 2023-02-27 | $19.92M derived: sum of 3 quarters · filed 2023-02-27 | $23.54M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $6.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $11.75M derived: sum of 2 quarters · filed 2023-02-27 | $15.38M derived: sum of 3 quarters · filed 2023-02-27 | $18.40M 10-K · filed 2023-02-27 |
| 2020-09-30 | $5.22M 10-Q · filed 2021-11-09 | $8.85M derived: sum of 2 quarters · filed 2021-11-09 | $11.86M 10-Q · filed 2021-11-09 | $14.57M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $3.63M 10-Q · filed 2021-08-10 | $6.65M 10-Q · filed 2021-08-10 | $9.36M derived: sum of 3 quarters · filed 2022-02-23 | $11.08M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-03-31 | $3.02M 10-Q · filed 2021-05-11 | $5.73M derived: sum of 2 quarters · filed 2022-02-23 | $7.45M derived: sum of 3 quarters · filed 2022-02-23 | $9.03M derived: sum of 4 quarters · filed 2022-02-23 |
| 2019-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $4.43M derived: sum of 2 quarters · filed 2022-02-23 | $6.01M derived: sum of 3 quarters · filed 2022-02-23 | $7.22M 10-K · filed 2022-02-23 |
| 2019-09-30 | $1.72M 10-Q · filed 2020-11-12 | $3.30M derived: sum of 2 quarters · filed 2020-11-12 | $4.51M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $1.58M 10-Q · filed 2020-08-11 | $2.79M 10-Q · filed 2020-08-11 | ||
| 2018-12-31 | $3.99M 10-K · filed 2021-03-09 |